comparemela.com

Latest Breaking News On - Operational progress - Page 1 : comparemela.com

Vivoryon Therapeutics N V to Report Q1 2024 Financial Results and Operational Progress on May 23, 2024

Vivoryon Therapeutics N.V. to Report Q1 2024 Financial Results and Operational Progress on May 23, 2024 Halle / Munich, Germany, May 15, 2024 - Vivoryon Therapeutics N.V. , a clinical stage.

Xlife Sciences AG Publishes 2023 Annual Report - adhoc - Börsennachrichten

Xlife Sciences AG Key word Annual Results Xlife Sciences AG Publishes 2023 Annual Report 23Apr2024 0700 CETCEST Release of an ad hoc announcement pursuant to Art 53 LR The issuer is solely responsibl

Xlife Sciences AG Publishes 2023 Annual Report

Xlife Sciences AG / Key word: Annual Results Xlife Sciences AG Publishes 2023 Annual Report 23-Apr-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The.

Vivoryon Therapeutics N V to Report Q3 2023 Financial

Vivoryon Therapeutics N.V. to Report Q3 2023 Financial Results and Operational Progress on December 6, 2023 Halle (Saale) / Munich, Germany,.

Vivoryon Therapeutics N V to Report Q3 2023 Financial Results and Operational Progress on December 6, 2023

Vivoryon Therapeutics N.V. to Report Q3 2023 Financial Results and Operational Progress on December 6, 2023 Halle / Munich, Germany, November 28, 2023 - Vivoryon Therapeutics N.V. , a.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.